Display options
Cite
Schaefer C, Weber-Schoendorfer C. Pharmakotherapie in der Schwangerschaft. [Drug therapy during pregnancy]. Internist (Berl). 2009;50(4):455-65; quiz 466doi: 10.1007/s00108-009-2332-z.
Schaefer, C., & Weber-Schoendorfer, C. (2009). Pharmakotherapie in der Schwangerschaft. [Drug therapy during pregnancy]. Der Internist, 50(4), 455-65; quiz 466. https://doi.org/10.1007/s00108-009-2332-z
Schaefer, C, and Weber-Schoendorfer, C. "Pharmakotherapie in der Schwangerschaft." [Drug therapy during pregnancy]. Der Internist vol. 50,4 (2009): 455-65; quiz 466. doi: https://doi.org/10.1007/s00108-009-2332-z
Schaefer C, Weber-Schoendorfer C. Pharmakotherapie in der Schwangerschaft. [Drug therapy during pregnancy]. Internist (Berl). 2009 Apr;50(4):455-65; quiz 466. doi: 10.1007/s00108-009-2332-z. German. PMID: 19305958.
Copy Download .nbib Format: NLM
Share it on

Internist (Berl). 2009 Apr;50(4):455-65; quiz 466. doi: 10.1007/s00108-009-2332-z.

[Drug therapy during pregnancy].

Der Internist

[Article in German]
C Schaefer, C Weber-Schoendorfer

Affiliations

  1. Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie, Berliner Betrieb für Zentrale Gesundheitliche Aufgaben, Spandauer Damm 130, Berlin, Germany. [email protected]

PMID: 19305958 DOI: 10.1007/s00108-009-2332-z

Abstract

Most acute and chronic diseases do not require termination of a pregnancy nor is a pregnancy a reason to withhold necessary drug therapy. As many pregnancies are unplanned, any drug treatment during reproductive age should consider the occurrence of a pregnancy. Wherever possible, only medicinal drugs with sufficient documentation in pregnant women not indicating developmental toxicity should be chosen. There are acceptable drugs for the majority of diseases, although many of them are labeled as contraindicated during pregnancy. This article provides an overview on prenatal risks of ACE-inhibitors, AT II-receptor antagonists, antiepileptics, SSRI, atypical neuroleptics, lithium, coumarin anticoagulants, retinoids, selected antibiotics, immunomodulatory drugs and provides treatment recommendations for the most common diseases.

References

  1. Reprod Toxicol. 2005 Jul-Aug;20(2):209-14 - PubMed
  2. Birth Defects Res A Clin Mol Teratol. 2008 Sep;82(9):605-9 - PubMed
  3. J Rheumatol. 2009 Mar;36(3):635-41 - PubMed
  4. Br J Clin Pharmacol. 2008 Nov;66(5):695-705 - PubMed
  5. Arthritis Rheum. 2003 Nov;48(11):3207-11 - PubMed
  6. Nephrol Dial Transplant. 2007 Sep;22(9):2722 - PubMed
  7. J Rheumatol. 2000 Aug;27(8):1872-5 - PubMed
  8. Pediatrics. 2004 Feb;113(2):368-75 - PubMed
  9. Teratology. 2002 Sep;66(3):127-40 - PubMed
  10. Birth Defects Res A Clin Mol Teratol. 2003 Jun;67(6):403-8 - PubMed
  11. Teratology. 2002 May;65(5):240-61 - PubMed
  12. Am J Gastroenterol. 2004 Dec;99(12):2385-92 - PubMed
  13. Reprod Toxicol. 2008 Apr;25(3):390-1; author reply 392 - PubMed
  14. Thromb Haemost. 2006 Jun;95(6):949-57 - PubMed
  15. Eur J Obstet Gynecol Reprod Biol. 1996 Nov;69(2):83-9 - PubMed
  16. J Rheumatol. 2004 Dec;31(12):2360-5 - PubMed

MeSH terms

Publication Types